Corasore – heptaminol For Hypotension
Each tablet contains: heptaminol H(I 18Z8 mg. e.q. to heptaminol 150 mg.
Each 1 mL oral drops (= 25 drops) contains 150 mg heptaminol.
Heptaminol (Corasore) is a cardiac stimulant (having a positive inotropic action). It increases coronary blood flow with a slight peripheral vasoconstrictor properties and mild C.N.S. stimulant effect. Heptaminol has no cumulative action.
Hypotension, fainting tendency and slight to moderately severe circulatory collapse.
Asthenia, nervous and physical fatigue in general and sporting medicine.
Adjuvant treatment of mild and moderate cases of heart failure particularly incipient pulmonary edema.
Heart failure associated with toxic, infectious, degenerative or arteriosclerotic myocardial disease.
There are no Known contraindications to the use of heptaminol.
Precautions & Interactions
Hypertension : Patients treated with theophylline derivatives.
A mild tachycardia, palpitation, dizziness or gastric upsets may rarely occur.
Dosage & Administration
Infants & children under 12 years: 4-16 drops (25 -100 mg) depending on age, 2 – 4 times daily, up to 6 times daily if necessary, or as directed by the physician
Adults & children over 12 years: One tablet or 25 drops, (150 mg) 2-4 times daily, up to 6 timesdaily if necessary, or as directed by the physician.
Strips of 10 tablets.
Dropper bottle of 15 mL.
Corasore® Tablets: Store at temperature not exceeding 30°(in dry place.(
Corasore® Drops: Store at temperature not exceeding 30°.
Keep all medicaments out of reach of children
Product of: AMOUN PHARMACEUTICAL CO. S.A.E. EI-Obour City, Cairo, Egypt.
Corasore – patient information leaflet
[pdf-embedder url=”https://www.pharmatop1.com/wp-content/uploads/2018/08/CORASORE-PATIENT-INFORMATION-LEAFLET.pdf” title=”CORASORE – PATIENT INFORMATION LEAFLET”]